DDrare: Database of Drug Development for Rare Diseases

Exposure to one or more disease-modifying drug(s)(dmds) used to treat ms (DrugBank: -)

告示番号	疾患名（ページ内リンク）	臨床試験数
13	多発性硬化症／視神経脊髄炎	1

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04472975 (ClinicalTrials.gov)	January 1, 1996	3/7/2020	Prescription Drug Safety and Effectiveness in Multiple Sclerosis	Disease-modifying Drug Safety and Effectiveness in Multiple Sclerosis [DRUMS]	Multiple Sclerosis	Drug: Exposure to one or more disease-modifying drug(s)(DMDs) used to treat MS	University of British Columbia	University of Manitoba;Dalhousie University;University of Saskatchewan;Alberta Health Services;University of Alberta	Completed	18 Years	N/A	All	35000		NULL

No.

TrialID

Date_
enrollment

Date_
registration

Public_title

Scientific_title

Condition

Intervention

Primary_
sponsor

Secondary_
sponsor

Recruitment_
Status

Inclusion_
agemin

Inclusion_
agemax

Inclusion_
gender

Target_
size

Phase

Countries

January 1, 1996

3/7/2020

Prescription Drug Safety and Effectiveness in Multiple Sclerosis

Disease-modifying Drug Safety and Effectiveness in Multiple Sclerosis [DRUMS]

Multiple Sclerosis

Drug: Exposure to one or more disease-modifying drug(s)(DMDs) used to treat MS

University of British Columbia

University of Manitoba;Dalhousie University;University of Saskatchewan;Alberta Health Services;University of Alberta

Completed

18 Years

N/A

All

35000

NULL